Day: October 25, 2019

Form 8.3 – Green REIT plc

Written by Customer Service on October 25, 2019. Posted in Mergers And Acquisitions.

FORM 8.3IRISH TAKEOVER PANELDISCLOSURE UNDER RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2013DEALINGS BY PERSONS WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE1. KEY INFORMATION2. INTERESTS AND SHORT POSITIONS(a) Interests and short positions (following dealing) in the class of relevant security dealt in (Note 3)(b) Interests and short positions in relevant securities of the company, other than the class dealt in (Note 3) 3. DEALINGS (Note 4)(a) Purchases and sales (b) Derivatives transactions (other than options transactions)(c) Options transactions in respect of existing relevant securities(i) Writing, selling, purchasing or varying(ii) Exercising(d) Other dealings (including transactions in respect of new securities) (Note 4)4. OTHER INFORMATIONAgreements, arrangements...

Hubbell Incorporated Declares 8% Dividend Increase

Written by Customer Service on October 25, 2019. Posted in Dividend Reports And Estimates.

Shelton, CT, Oct. 25, 2019 (GLOBE NEWSWIRE) — The Board of Directors of Hubbell Incorporated (NYSE: HUBB) today declared an 8% increase in the common stock dividend rate. The new annual payment of $3.64 per share, or $0.91 per quarter, compares to the former rate of $3.36 or $0.84 per quarter. The dividend will be paid on December 16, 2019 to shareholders of record on November 29, 2019.Hubbell Incorporated is an international manufacturer of quality electrical and electronic products for a broad range of non-residential and residential construction, industrial and utility applications. With 2018 revenues of $4.5 billion, Hubbell Incorporated operates manufacturing facilities in the United States and around the world. The corporate headquarters is located in Shelton, CT.#######Dan InnamoratoHubbell Incorporated40 Waterview DriveP.O....

Corline Biomedical AB: Inga negativa säkerhetsfynd i RENAPAIR 01 efter fyra patienter – Sahlgrenska och Karolinska adderas till studien

Written by Customer Service on October 25, 2019. Posted in Public Companies.

Säkerhetskommittén för Corlines njurtransplantationsstudie RENAPAIR 01 har utvärderat säkerhetsdata för de fyra första patienterna som behandlats vid Akademiska sjukhuset i Uppsala. Inga negativa säkerhetsfynd kopplade till Renaparin® konstaterades och Corline har idag därför beslutat utöka patientrekryteringen även till transplantationsklinikerna vid Sahlgrenska Universitetssjukhuset och Karolinska Universitetssjukhuset.Det primära syftet med RENAPAIR 01 är att fastställa att Renaparin® är säkert att administrera i samband med njurtransplantation. Studien omfattar totalt 18 patienter och för de återstående 14 patienterna tillåts parallell inkludering vid de tre transplantationskliniker som ingår i undersökningen. Ingen ytterligare interimsanalys av data kommer att ske före studiens slut.Henrik Nittmar, VD i Corline, kommenterar”De fyra...

Freddie Mac Prices $287 Million Offering of Guaranteed Tax-Exempt ML Certificates

Written by Customer Service on October 25, 2019. Posted in Public Companies.

MCLEAN, Va., Oct. 25, 2019 (GLOBE NEWSWIRE) — Freddie Mac (OTCQB: FMCC) recently priced a new offering of credit risk transfer securities backed by Tax-Exempt Loans (TELs) made by state or local housing agencies and secured by affordable rental housing. This is the company’s sixth ML Certificate offering, and the second to offer fixed-rate securities.The company expects to guarantee approximately $287 million in fixed-rate ML Certificates (ML-06 Certificates) that are supported by pools of fixed-rate TELs. Freddie Mac has divided the securities into California only and non-California classes, allowing California’s state tax exemption to pass through to investors in the California classes. The ML-06 Certificates are expected to settle on or about October 30, 2019.ML Certificates are designed to create more liquidity for affordable...

PURA – Puration Announces THC Beverage Launch Plans

Written by Customer Service on October 25, 2019. Posted in Public Companies.

DALLAS, Oct. 25, 2019 (GLOBE NEWSWIRE) — via OTC PR WIRE – Puration, Inc. (USOTC: PURA) today announced THC beverage launch plans. With Canada legalizing cannabis infused beverages this month, PURA is moving forward with its already designed THC Savor beverage. Utilizing its sole license of Kali-Extracts’ (USOTC: KALY) U.S. Patented Cannabis Extraction Process, PURA has designed a THC infused beverage named THC Savor. Next Thursday, October 31, PURA will announce its rollout plans for THC Savor in Canada.PURA realized $1 million in revenue last year in 2018 and then reported another $1 million in revenue in just the first six months of 2019. PURA management has set a $4 million revenue target for year-end 2019. With PURA’s growing number of new distribution agreements in strategic markets, a recent analyst projection has PURA...

Bempedoic Acid Included in Top 10 Medical Innovations for 2020 List

Written by Customer Service on October 25, 2019. Posted in Public Companies.

ANN ARBOR, Mich., Oct. 25, 2019 (GLOBE NEWSWIRE) — Esperion (NASDAQ:ESPR) announced that bempedoic acid was included in the “Top 10 Medical Innovations for 2020” at Cleveland Clinic’s 2019 Medical Innovation Summit on Wednesday, October 23rd. The Summit was comprised of a panel of physicians and scientists assembled to assess innovations and medicines that have the potential to enhance healthcare in the coming year. Bempedoic acid and the bempedoic acid / ezetimibe combination tablet are under review by the U.S. Food and Drug Administration (FDA) and European Medicines Agency (EMA).“We are very pleased that bempedoic acid was included in Cleveland Clinic’s Top 10 Medical Innovations for 2020,” said Tim M. Mayleben, president and chief executive officer of Esperion. “This recognition highlights the need for innovative and cost-effective,...

Spark Therapeutics Wins Prix Galien USA Award for LUXTURNA® (voretigene neparvovec-rzyl) as Best Biotechnology Product

Written by Customer Service on October 25, 2019. Posted in Public Companies.

PHILADELPHIA, Oct. 25, 2019 (GLOBE NEWSWIRE) — Spark Therapeutics (NASDAQ:ONCE), a fully integrated, commercial gene therapy company dedicated to challenging the inevitability of genetic disease, today announced that the Galien Foundation has awarded the prestigious 2019 Prix Galien USA Award for Best Biotechnology Product to LUXTURNA® (voretigene neparvovec-rzyl). The award, announced at the Prix Galien USA Awards Ceremony on Oct. 24, 2019 at the American Museum of Natural History in New York City, recognizes the development of the world’s most innovative medicines that help improve the overall human condition.“We are honored that LUXTURNA, the first gene therapy for an inherited disease in the U.S., was awarded the prestigious 2019 Prix Galien USA Award for Best Biotechnology Product,” said Katherine A. High, M.D., president and...

Correction: AS VALMIERAS STIKLA ŠĶIEDRA notification regarding possession of significant amount of capital shares

Written by Customer Service on October 25, 2019. Posted in Public Companies.

CORRECTION: described at section “10.Papildu informācija” in the attached documents.Additional information available in the documents attached.Additional information:AS VALMIERAS STIKLA ŠĶIEDRATel.: +371 6420 2216E-mail: latvia@valmiera-glass.comwww.valmiera-glass.comAttachmentsNozimiga_lidzdaliba_HJPDNozimiga_lidzdaliba_PDAC

PRECIZĒJUMS: AS VALMIERAS STIKLA ŠĶIEDRA paziņojums par nozīmīgu līdzdalību

Written by Customer Service on October 25, 2019. Posted in Public Companies.

LABOJUMS: skaidrots “10.Papildu informācija” pievienotajos dokumentos.Papildu informācija pievienotajos dokumentos.Papildu informācija:AS VALMIERAS STIKLA ŠĶIEDRATālr.: +371 6420 2216E-pasts: latvia@valmiera-glass.comwww.valmiera-glass.comPielikumiNozimiga_lidzdaliba_HJPDNozimiga_lidzdaliba_PDAC

ISRAMCO, INC. ANNOUNCES COMPLETION OF MERGER

Written by Customer Service on October 25, 2019. Posted in Public Companies.

HOUSTON, TX , Oct. 25, 2019 (GLOBE NEWSWIRE) — Isramco, Inc. (NASDAQ CM: ISRL) (“Isramco” or the “Company”), announced today the completion of the merger (the “Merger”) contemplated by the previously announced Agreement and Plan of Merger, dated as of May 20, 2019 (the “Merger Agreement”), by and among the Company, Naphtha Israel Petroleum Corporation Ltd. (“Naphtha”), Naphtha Holding Ltd. (“NHL”), I.O.C. – Israel Oil Company, LTD. (“IOC”) and Naphtha US Oil, Inc. (“Merger Sub” and, together with Naphtha, NHL and IOC, the “Naphtha Group”).The Merger, originally announced on May 20, 2019, was approved by the Company’s stockholders at a special meeting held on October 22, 2019. Under the terms of the Merger Agreement, Isramco stockholders receive US $121.40 per share of Company common stock.As a result of the Merger, Isramco became...

Day: October 25, 2019

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals